Singapore Court of Appeal Maintains Injunction in KBP Biosciences and Novo Nordisk Arbitration
On May 21, 2026, KBP Biosciences announced that the Singapore Court of Appeal upheld a temporary injunction against the company and its founder, Dr. Huang Zhenhua, pending the out...